Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients.
Galectin-3 (Gal-3) is a member of the beta-galactoside-binding lectins family and has been implicated in angiogenesis, tumor invasion, and metastatic process in vitro and in vivo. As we showed recently that advanced melanoma patients presented high serum level of Gal-3, we investigated the association of this protein with the outcome of melanoma patients. Whether this protein could be a biomarker has not been assessed, and we compared the prognostic value of serum Gal-3 in multivariate analysis with lactate dehydrogenase, C-reactive protein and S100B. We conclude that Gal-3 could be of prognostic value in melanoma patients; more precisely, this protein has a strong independent prognostic signification with a cut-off value of 10 ng/ml. After these data, we believe that serum Gal-3 measurement can have an important role in the follow-up and management of advanced American Joint Commission on Cancer stage III and stage IV melanoma patients. Further studies will uncover whether Gal-3 will be able to open new therapeutic perspectives.
Vereecken
Pierre
P
Department of Dermatology, CHU-Brugmann, Erasme Hospital, Brussels, Belgium. pvereeck@ulb.ac.be
Awada
Ahmad
A
Suciu
Stefan
S
Castro
Gilberto
G
Morandini
Renato
R
Litynska
Anna
A
Lienard
Danielle
D
Ezzedine
Khaled
K
Ghanem
Ghanem
G
Heenen
Michel
M
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood*; D002097:C-Reactive Protein / Q000378:metabolism; D005260:Female; D037502:Galectin 3 / Q000097:blood*; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008545:Melanoma / Q000097:blood* / Q000473:pathology / Q000556:secondary; D008875:Middle Aged; D015999:Multivariate Analysis; D009367:Neoplasm Staging; D011379:Prognosis; D009418:S100 Proteins / Q000097:blood; D016019:Survival Analysis; D055815:Young Adult
D014408:Biomarkers, Tumor; D037502:Galectin 3; D009418:S100 Proteins; D002097:C-Reactive Protein